MX2022009469A - Composiciones de sal-acido mezcladas de r-beta-hidroxibutirato enantiomericamente puro. - Google Patents

Composiciones de sal-acido mezcladas de r-beta-hidroxibutirato enantiomericamente puro.

Info

Publication number
MX2022009469A
MX2022009469A MX2022009469A MX2022009469A MX2022009469A MX 2022009469 A MX2022009469 A MX 2022009469A MX 2022009469 A MX2022009469 A MX 2022009469A MX 2022009469 A MX2022009469 A MX 2022009469A MX 2022009469 A MX2022009469 A MX 2022009469A
Authority
MX
Mexico
Prior art keywords
beta
enantiomerically pure
hydroxybutyrate
mixed salt
acid
Prior art date
Application number
MX2022009469A
Other languages
English (en)
Inventor
Gary Millet
Original Assignee
Axcess Global Sciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axcess Global Sciences Llc filed Critical Axcess Global Sciences Llc
Publication of MX2022009469A publication Critical patent/MX2022009469A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una composición de sal-ácido mezclada de R-beta-hidroxibutirato cetogénica incluye ácido R-beta-hidroxibutírico enantioméricamente puro y una o más sales de R-beta-hidroxibutirat o enantioméricamente puro. El ácido R-beta-hidroxibutírico es más rápidamente absorbido y utilizado por el cuerpo que las sales o ésteres, aumenta el sabor, y reduce la necesidad de incluir ácido cítrico u otros ácidos comestibles. La sal(es) de R-beta-hidroxibutirato enantioméricamente puro es más lentamente absorbida y utilizada por el cuerpo y puede proporcionar uno o más electrolitos. Las composiciones para incrementar el nivel de cuerpo de cetona en un sujeto puede contener un portador dietéticamente o farmacéuticamente aceptable y una composición de sal-ácido mezclada de R-beta- hidroxibutirato. La composición contiene menos de 100% por equivalentes molares de sales de R-beta-hidroxibutirato enantioméricamente puro totales y más de 0% por equivalentes molares de ácido R-beta-hidroxibutírico enantioméricamente puro.
MX2022009469A 2020-02-06 2021-02-08 Composiciones de sal-acido mezcladas de r-beta-hidroxibutirato enantiomericamente puro. MX2022009469A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16/783,907 US11241401B2 (en) 2020-02-06 2020-02-06 Enantiomerically pure r-beta-hydroxybutyrate mixed salt-acid compositions
PCT/US2021/017078 WO2021159070A1 (en) 2020-02-06 2021-02-08 Enantiomerically pure r-beta-hydroxybutyrate mixed salt-acid compositions

Publications (1)

Publication Number Publication Date
MX2022009469A true MX2022009469A (es) 2022-08-25

Family

ID=77177353

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022009469A MX2022009469A (es) 2020-02-06 2021-02-08 Composiciones de sal-acido mezcladas de r-beta-hidroxibutirato enantiomericamente puro.

Country Status (7)

Country Link
US (1) US11241401B2 (es)
EP (1) EP4099848A4 (es)
CN (1) CN115835786A (es)
AU (1) AU2021216437A1 (es)
CA (1) CA3166226C (es)
MX (1) MX2022009469A (es)
WO (1) WO2021159070A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115251375A (zh) * 2022-07-11 2022-11-01 珠海麦得发生物科技股份有限公司 一种(r)-3-羟基丁酸生酮产品及其制备方法

Family Cites Families (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2238149A (en) 1937-11-02 1941-04-15 Aeckerle Emil Process for improving the stability of hygroscopic substances
US2976073A (en) 1959-05-25 1961-03-21 Russell Knob assembly
US4627808A (en) 1985-05-31 1986-12-09 Hughes Raymond J Apparatus for making capsule having plural chambers
WO1987003808A1 (en) 1985-12-18 1987-07-02 Veech Richard L Fluid therapy with l-lactate and/or pyruvate anions
US4997976A (en) 1988-11-15 1991-03-05 Henri Brunengraber Use of 1,3-butanediol acetoacetate in parenteral oral nutrition
US5288512A (en) 1987-12-15 1994-02-22 The Procter & Gamble Company Reduced calorie fats made from triglycerides containing medium and long chain fatty acids
US5292774A (en) 1988-07-26 1994-03-08 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Substitution fluid preparation comprising 3-hydroxy-butyric acid (β-hydroxybutric acid) and its salts
SE8803141L (sv) 1988-09-07 1990-03-08 Kabivitrum Ab Naeringsmedel foer maenniskor och djur
US5116868A (en) 1989-05-03 1992-05-26 The Johns Hopkins University Effective ophthalmic irrigation solution
US5654266A (en) 1992-02-10 1997-08-05 Chen; Chung-Ho Composition for tissues to sustain viability and biological functions in surgery and storage
JPH08336393A (ja) 1995-04-13 1996-12-24 Mitsubishi Chem Corp 光学活性なγ−置換−β−ヒドロキシ酪酸エステルの製造法
AU749638B2 (en) 1997-03-17 2002-06-27 Btg International Limited Therapeutic compositions
US6316038B1 (en) 1997-03-17 2001-11-13 Btg International Limited Therapeutic compositions
US6323237B1 (en) 1997-03-17 2001-11-27 Btg International Limited Therapeutic compositions
US20090253781A1 (en) 2002-05-24 2009-10-08 Btg International Limited Therapeutic compositions
JPH1160434A (ja) 1997-08-12 1999-03-02 Kanebo Ltd 皮膚老化防止化粧料
ATE283056T1 (de) 1998-07-22 2004-12-15 Metabolix Inc Nahrungs- und therapeutische verwendung von hydroxyalkanoat oligomere
NZ509739A (en) 1998-09-15 2003-10-31 Btg Int Ltd A cyclic ester of (R)-3-hydroxybutyrate useful for increasing cardiac efficiency
TWI249401B (en) 1999-04-14 2006-02-21 Takeda Chemical Industries Ltd Agent for improving ketosis
US20070179197A1 (en) 2000-05-01 2007-08-02 Accera, Inc. Compositions and methods for improving or preserving brain function
US6835750B1 (en) 2000-05-01 2004-12-28 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
DE60138019D1 (de) 2000-05-01 2009-04-30 Accera Inc Verwendung von triglyceriden mit mittellangen ketten zur behandlung und vorbeugung der alzheimerschen erkrankung
US6613356B1 (en) 2000-10-10 2003-09-02 Victor Vlahakos Weight loss medication and method
US20050129783A1 (en) 2001-04-19 2005-06-16 Mccleary Edward L. Composition and method for treatment of neurophysiological conditions and maintenance of neurophysiological health
US6706756B1 (en) 2001-11-16 2004-03-16 University Of South Florida Vasodilating compound and method of use
AU2003219796A1 (en) 2002-02-20 2003-09-09 Beth Israel Deaconess Medical Center Conjugates comprising a biodegradable polymer and uses therefor
WO2004108740A2 (en) 2003-06-03 2004-12-16 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nutritional supplements and therapeutic compositions comprising (r)-3-hydroxybutyrate derivatives
US8158184B2 (en) 2004-03-08 2012-04-17 Bunge Oils, Inc. Structured lipid containing compositions and methods with health and nutrition promoting characteristics
GB0410266D0 (en) 2004-05-07 2004-06-09 Ketocytonyx Inc Treatment of apoptosis
GB0420856D0 (en) 2004-09-20 2004-10-20 Ketocytonyx Inc Cns modulators
EP2468273A3 (en) 2005-06-20 2012-07-11 Accera, Inc. Method to reduce oxidative damage and improve mitochondrial efficiency
HUE040002T2 (hu) 2006-04-03 2019-02-28 Accera Inc Ketogén vegyületek alkalmazása korfüggõ memóriazavar kezelésére
WO2008005818A1 (en) 2006-06-30 2008-01-10 Stepan Co Glyceride esters for the treatment of diseases associated with reduced neuronal metabolism of glucose
WO2008021394A2 (en) 2006-08-15 2008-02-21 Theraquest Biosciences, Llc Pharmaceutical formulations of cannabinoids and method of use
WO2008024408A2 (en) 2006-08-22 2008-02-28 Theraquest Biosciences, Inc. Pharmaceutical formulations of cannabinoids for application to the skin and method of use
CN101678043A (zh) * 2007-03-30 2010-03-24 有限会社爱泽世 生酮作用促进剂组合物
JP2010523714A (ja) 2007-04-12 2010-07-15 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ 虚血／再灌流保護組成物および使用法
CA3099446A1 (en) 2007-11-30 2009-06-11 Zynerba Pharmaceuticals, Inc. Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same
CN101969769A (zh) 2008-01-04 2011-02-09 伊希斯创新有限公司 用作降低血脂药剂的酮体和酮体酯
US8642654B2 (en) 2009-04-16 2014-02-04 Isis Innovation Limited Hydroxybutyrate ester and medical use thereof
CA2984935C (en) 2009-02-24 2021-01-12 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
AU2009345154A1 (en) 2009-04-29 2011-12-22 University Of Kentucky Research Foundation Cannabinoid-containing compositions and methods for their use
GB201002983D0 (en) 2010-02-22 2010-04-07 Tdeltas Ltd Nutritinal composition
US20120213756A1 (en) 2011-02-21 2012-08-23 Rosemary Petralia Nutraceutical beverage
WO2013130767A1 (en) 2012-02-29 2013-09-06 Pulmatrix, Inc. Inhalable dry powders
GB201206192D0 (en) 2012-04-05 2012-05-23 Tdeltas Ltd Ketone bodies and ketone body esters and for maintaining or improving muscle power output
MX371259B (es) 2013-03-19 2020-01-23 Univ South Florida Composiciones y métodos para producir cetosis elevada y sostenida.
GB201314127D0 (en) 2013-08-07 2013-09-18 Tdeltas Ltd Ketone body and ketone body ester for reducing muscle breakdown
AU2014348672A1 (en) 2013-11-12 2016-06-02 Ortho-Nutra, Llc Theacrine-based supplement and method of use thereof
JP2016537996A (ja) 2013-11-18 2016-12-08 ケーエフエスユー リミテッド 酸逆流性疾患および胃食道逆流性疾患（ｇｏｒｄ／ｇｅｒｄ）の治療のための栄養補助食品
EP3094321B1 (en) 2014-01-13 2019-05-01 University Of South Florida Methods of sustaining dietary ketosis and its effects on lipid profile
WO2015175536A1 (en) 2014-05-12 2015-11-19 BiOWiSH Technologies, Inc. Compositions and methods for improving human health and nutrition
US20170298339A1 (en) 2014-10-07 2017-10-19 Stc.Unm Engineered Stable Microorganism/Cell Communities
US10292592B2 (en) 2014-11-13 2019-05-21 The Board Of Trustees Of The Leland Stanford Junior University Method and apparatus for optical recording of biological parameters in freely moving animals
US20180008629A1 (en) 2015-01-29 2018-01-11 Yale University Compositions and Methods for Treating NLRP3 Inflammasome-Related Diseases and Disorders
BR112017018944A2 (pt) 2015-03-02 2018-05-15 Afgin Pharma Llc método de tratamento de um estado ou condição de doença em humanos com um medicamento carbinóide, e, método de tratamento de um estado ou condição de doença em um mamífero diferente de um humano com medicamento(s) carbinóide(s)
US9364456B1 (en) 2015-06-30 2016-06-14 University Of South Florida Ketone esters for treatment of angelman syndrome
US10987340B2 (en) 2015-07-24 2021-04-27 Jesse Alexander Galinski Composition and method for rapidly inducing an endogenous ketosis
US10596129B2 (en) 2017-11-22 2020-03-24 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US10973786B2 (en) 2016-03-11 2021-04-13 Axcess Global Sciences, Llc R-beta-hydroxybutyrate, S-beta-hydroxybutyrate, and RS-beta-hydroxybutyrate mixed salt compositions
US10245242B1 (en) 2017-11-22 2019-04-02 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US10596130B2 (en) 2017-12-19 2020-03-24 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the S-enantiomer and methods of use
US10736861B2 (en) 2016-03-11 2020-08-11 Axcess Global Sciences, Llc Mixed salt compositions for producing elevated and sustained ketosis
US10596131B2 (en) 2017-11-22 2020-03-24 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US10292952B2 (en) 2016-03-11 2019-05-21 Axcess Global Sciences, Llc Mixed salt compositions for maintaining or restoring electrolyte balance while producing elevated and sustained ketosis
US10245243B1 (en) 2017-12-19 2019-04-02 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the S-enantiomer and methods of use
WO2017165443A1 (en) 2016-03-21 2017-09-28 Csilla Ari D'agostino Methods of improving motor function using ketone supplementation
US10376482B2 (en) 2016-04-03 2019-08-13 Franco Cavaleri Butyrate and beta-hydroxybutyrate compositions
WO2017184788A1 (en) * 2016-04-19 2017-10-26 Keto Patent Group, Inc. Administration of butyrate, beta-hydroxybutyrate, and related compounds in humans
US11337945B2 (en) 2016-06-01 2022-05-24 Keto Innovations, Llc C5 ketone compositions, and related methods, for therapeutic and performance supplementation
US10588877B2 (en) 2016-07-21 2020-03-17 Savind, Inc. Compositions comprising β-hydroxybutyric acid and salt, and methods of using the same
US20180057846A1 (en) * 2016-08-30 2018-03-01 KetoneAid Inc. Partially buffered free acid and/or ketone blend for rapid onset ketosis and metabolic therapy
US20180055797A1 (en) * 2016-08-31 2018-03-01 KetoneAid Inc. Non-racemic ketone salts for rapid-onset nutritional ketosis and metabolic therapy
EP3538078A4 (en) 2016-11-11 2020-07-08 Bennes, Inc. FORMULATIONS FOR EFFICIENT CANNABINOID DELIVERY
FR3060432B1 (fr) 2016-12-16 2019-05-24 Lectra Procede de partitionnement d'un placement predetermine de pieces destinees a etre decoupees dans un materiau souple en feuille
WO2018187852A1 (en) * 2017-04-12 2018-10-18 Cavaleri Franco Butyrate and beta-hydroxybutyrate compositions and methods of use thereof
JP7442095B2 (ja) 2017-07-21 2024-03-04 バック・インスティテュート・フォー・リサーチ・オン・エイジング ベータ－ヒドロキシブチレート及びブタンジオールのｓ－エナンチオマー並びにその使用方法
US10925843B2 (en) 2018-04-18 2021-02-23 Axcess Global Sciences, Llc Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate
US20190313682A1 (en) 2018-04-12 2019-10-17 Metabolic Recovery Systems, LLC Compositions and methods for supplementing the diet
JP7385930B2 (ja) 2018-06-15 2023-11-24 ユニバーシティ オブ タスマニア サトウキビ由来の全植物繊維抽出物を使用した炎症性腸疾患の治療のための製剤
CN109480284A (zh) * 2018-12-05 2019-03-19 上海欣海生物科技有限公司 一种生酮食品及其制备方法

Also Published As

Publication number Publication date
CA3166226A1 (en) 2021-08-12
US11241401B2 (en) 2022-02-08
WO2021159070A1 (en) 2021-08-12
EP4099848A1 (en) 2022-12-14
CN115835786A (zh) 2023-03-21
CA3166226C (en) 2023-09-12
EP4099848A4 (en) 2024-03-06
US20210244690A1 (en) 2021-08-12
AU2021216437A1 (en) 2022-09-15

Similar Documents

Publication Publication Date Title
DE2556100C2 (es)
US6620425B1 (en) Food supplements and methods comprising lipoic acid and creatine
US4042684A (en) Dietetic beverage
US6908909B2 (en) Liquid oral compositions comprising a calcium compound and an acidulant
US5292774A (en) Substitution fluid preparation comprising 3-hydroxy-butyric acid (β-hydroxybutric acid) and its salts
US20090155379A1 (en) Nutritional composition for facilitating muscle pumps
CN101589808A (zh) 含姜黄素提取物的饮料制剂
JPH0748270A (ja) 肝患者栄養補給用の即時使用可能組成物
US20060210650A1 (en) Supplemental dietary composition for promoting weight loss
EA003376B1 (ru) Композиции, содержащие креатин в суспензии
EP0727947A1 (en) New beverage
MX2022009469A (es) Composiciones de sal-acido mezcladas de r-beta-hidroxibutirato enantiomericamente puro.
WO2019035953A1 (en) COMPOSITIONS AND METHODS FOR INCREASING MUSCLE MASS AND MUSCLE STRENGTH, TREATING SKIN, REDUCING WEAR AND DEGRADING FROM AGING AND EXPOSURE AND ENHANCING RECOVERY OF A STRESS SUCH AS EXERCISE AND TRAUMA
CN104082827A (zh) 一种食品保鲜剂
CN111838679A (zh) 一种新型高效营养膳食补充剂
US5424074A (en) Pharmaceutical composition for potassium supplementation
RU2018110274A (ru) Композиция минеральных веществ для стимуляции углеводного метаболизма
US6172114B1 (en) Creatine supplement
US8440241B1 (en) Alcohol metabolizing assisting supplement
JPH07227256A (ja) 経口液剤
US20150201650A1 (en) Dietary supplement
Antman et al. Magnesium in acute myocardial infarction: Scientific, statistical, and economic rationale for its use
EP1093337B1 (en) Food supplements comprising lipoic acid and creatine and methods for their use
CA2246014C (en) Food supplements and methods comprising lipoic acid and creatine
JPS58500526A (ja) 非経口栄養供給のための改良溶液